Ubs Asset Management Americas Inc Ptc Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

  • $379 Billion
  • Q1 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 178,755 shares of PTCT stock, worth $8.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
178,755
Previous 160,251 11.55%
Holding current value
$8.45 Million
Previous $7.23 Million 25.94%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 19, 2025
BUY
$41.81 - $57.17 $773,652 - $1.06 Million
18,504 Added 11.55%
178,755 $9.11 Million
Q4 2024

Feb 14, 2025
BUY
$34.99 - $52.07 $919,327 - $1.37 Million
26,274 Added 19.61%
160,251 $7.23 Million
Q3 2024

Nov 14, 2024
SELL
$30.39 - $37.66 $559,935 - $693,885
-18,425 Reduced 12.09%
133,977 $4.97 Million
Q2 2024

Aug 13, 2024
BUY
$24.69 - $40.12 $1.81 Million - $2.94 Million
73,305 Added 92.68%
152,402 $4.66 Million
Q4 2023

Feb 14, 2024
BUY
$18.07 - $29.37 $60,913 - $99,006
3,371 Added 4.45%
79,097 $2.18 Million
Q3 2023

Nov 13, 2023
BUY
$22.41 - $41.99 $50,108 - $93,889
2,236 Added 3.04%
75,726 $1.7 Million
Q1 2023

May 15, 2023
BUY
$38.16 - $48.86 $214,497 - $274,642
5,621 Added 8.28%
73,490 $3.56 Million
Q4 2022

Feb 14, 2023
SELL
$33.53 - $54.79 $6.51 Million - $10.6 Million
-194,100 Reduced 74.09%
67,869 $2.59 Million
Q3 2022

Nov 14, 2022
SELL
$41.85 - $53.85 $597,869 - $769,301
-14,286 Reduced 5.17%
261,969 $13.2 Million
Q2 2022

Aug 12, 2022
SELL
$25.6 - $45.23 $4.89 Million - $8.64 Million
-190,951 Reduced 40.87%
276,255 $11.1 Million
Q1 2022

May 16, 2022
SELL
$33.33 - $44.6 $433,556 - $580,156
-13,008 Reduced 2.71%
467,206 $17.4 Million
Q4 2021

Feb 14, 2022
BUY
$35.36 - $41.86 $102,685 - $121,561
2,904 Added 0.61%
480,214 $19.1 Million
Q3 2021

Nov 15, 2021
BUY
$37.01 - $44.74 $625,839 - $756,553
16,910 Added 3.67%
477,310 $17.8 Million
Q2 2021

Aug 16, 2021
BUY
$37.95 - $49.37 $5.47 Million - $7.12 Million
144,198 Added 45.6%
460,400 $19.5 Million
Q1 2021

May 14, 2021
SELL
$46.8 - $68.92 $5.99 Million - $8.82 Million
-127,940 Reduced 28.81%
316,202 $15 Million
Q4 2020

Mar 01, 2021
BUY
$47.96 - $67.64 $801,027 - $1.13 Million
16,702 Added 3.91%
444,142 $27.1 Million
Q3 2020

Nov 13, 2020
SELL
$45.41 - $57.07 $2.92 Million - $3.67 Million
-64,342 Reduced 13.08%
427,440 $20 Million
Q2 2020

Aug 14, 2020
BUY
$42.56 - $54.98 $5.26 Million - $6.8 Million
123,696 Added 33.61%
491,782 $25 Million
Q1 2020

May 15, 2020
SELL
$32.37 - $59.36 $987,932 - $1.81 Million
-30,520 Reduced 7.66%
368,086 $16.4 Million
Q4 2019

Feb 14, 2020
BUY
$32.22 - $50.07 $882,119 - $1.37 Million
27,378 Added 7.37%
398,606 $19.1 Million
Q3 2019

Nov 14, 2019
BUY
$33.82 - $48.17 $198,895 - $283,287
5,881 Added 1.61%
371,228 $12.6 Million
Q2 2019

Aug 15, 2019
BUY
$35.42 - $45.0 $2.06 Million - $2.62 Million
58,247 Added 18.97%
365,347 $0
Q1 2019

May 14, 2019
BUY
$28.09 - $39.49 $884,526 - $1.24 Million
31,489 Added 11.43%
307,100 $0
Q4 2018

Feb 13, 2019
BUY
$29.83 - $46.51 $518,057 - $807,739
17,367 Added 6.73%
275,611 $9.46 Million
Q3 2018

Nov 14, 2018
SELL
$33.9 - $47.77 $544,569 - $767,377
-16,064 Reduced 5.86%
258,244 $0
Q2 2018

Aug 14, 2018
SELL
$25.7 - $47.88 $740,160 - $1.38 Million
-28,800 Reduced 9.5%
274,308 $0
Q1 2018

May 14, 2018
SELL
$17.46 - $32.59 $1.02 Million - $1.9 Million
-58,385 Reduced 16.15%
303,108 $0
Q4 2017

Feb 09, 2018
BUY
$15.14 - $20.89 $490,475 - $676,752
32,396 Added 9.84%
361,493 $0
Q3 2017

Nov 13, 2017
BUY
$16.81 - $21.61 $5.53 Million - $7.11 Million
329,097
329,097 $0

Others Institutions Holding PTCT

# of Institutions
284
Shares Held
78.5M
Call Options Held
223K
Put Options Held
156K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.38B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email